)
)
)
CellVax Therapeutics Inc
CellVax Therapeutics is a privately held, clinical-stage biotech developing a novel cell-based immunotherapy platform to safely and cost-effectively reduce cancer recurrence. The company’s proprietary Tumor Presenting Cell (TPC) technology transforms a patient’s own tumor cells into potent antigen-presenting cells, activating both CD8+ cytotoxic T cells and CD4+ helper T cells against residual cancer.
Address
MiamiFlorida
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)